We found that Rufomycin 4–7 effectively decreased the generation of pro-inflammatory cytokines Il1b and Il6 in macrophages (Figure 2 and Supplementary Figure 3) as well as the intracellular survival of type strain and two clinical isolates of Mabs-R during infection (Figure 1 and Supplementary Figure 2). Here, IL6 is linked to infection.